BALCX
Price
$38.33
Change
+$0.10 (+0.26%)
Updated
Sep 15 closing price
Net Assets
263.06B
PGPCX
Price
$27.73
Change
+$0.11 (+0.40%)
Updated
Sep 15 closing price
Net Assets
2.29B
Interact to see
Advertisement

BALCX vs PGPCX

Header iconBALCX vs PGPCX Comparison
Open Charts BALCX vs PGPCXBanner chart's image
American Funds American Balanced C
Price$38.33
Change+$0.10 (+0.26%)
VolumeN/A
Net Assets263.06B
George Putnam Balanced C
Price$27.73
Change+$0.11 (+0.40%)
VolumeN/A
Net Assets2.29B
BALCX vs PGPCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BALCX vs. PGPCX commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Buy and PGPCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 263B vs. PGPCX (2.29B). BALCX pays higher dividends than PGPCX: BALCX (1.16) vs PGPCX (0.93). BALCX was incepted earlier than PGPCX: BALCX (25 years) vs PGPCX (26 years). PGPCX (1.68) is less costly to investors than BALCX (1.31). PGPCX is a more actively managed with annual turnover of: 80.00 vs. BALCX (44.00). PGPCX has a lower initial minimum investment than BALCX: PGPCX (0) vs BALCX (250). BALCX annual gain was more profitable for investors over the last year : 9.16 vs. PGPCX (8.37). BALCX return over 5 years is better than : 37.96 vs. PGPCX (28.66).
BALCXPGPCXBALCX / PGPCX
Total Expense Ratio1.311.6878%
Annual Report Gross Expense Ratio1.311.6878%
Fund Existence25 years26 years-
Gain YTD12.8679.721132%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets263B2.29B11,510%
Annual Yield % from dividends1.160.93125%
Returns for 1 year9.168.37109%
Returns for 3 years40.6243.6193%
Returns for 5 years37.9628.66132%
Returns for 10 years71.7280.0890%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOC18.250.17
+0.94%
Healthpeak Properties
RDHL1.50-0.01
-0.66%
Redhill Biopharma Ltd
LE15.47-0.11
-0.71%
Lands' End
OCUL12.54-0.27
-2.11%
Ocular Therapeutix
STTK1.79-0.13
-6.77%
Shattuck Labs